112 related articles for article (PubMed ID: 12470711)
1. Synthesis and pharmacological characterisation of 2,4-dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists.
Micheli F; Fabio RD; Cavanni P; Rimland JM; Capelli AM; Chiamulera C; Corsi M; Corti C; Donati D; Feriani A; Ferraguti F; Maffeis M; Missio A; Ratti E; Paio A; Pachera R; Quartaroli M; Reggiani A; Sabbatini FM; Trist DG; Ugolini A; Vitulli G
Bioorg Med Chem; 2003 Jan; 11(2):171-83. PubMed ID: 12470711
[TBL] [Abstract][Full Text] [Related]
2. 2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: an exploration of the role of the pyrrolic scaffold.
Micheli F; Di Fabio R; Cavanni P; Donati D; Faedo S; Gehanne S; Maffeis M; Marchioro C; Sabbatini FM; Tarzia G; Tranquillini ME; Viziano M
Farmaco; 2003 Oct; 58(10):1005-9. PubMed ID: 14505730
[TBL] [Abstract][Full Text] [Related]
3. 2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: further characterization of 3,5-dimethyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester and structure-activity relationships.
Micheli F; Di Fabio R; Bordi F; Cavallini P; Cavanni P; Donati D; Faedo S; Maffeis M; Sabbatini FM; Tarzia G; Tranquillini ME
Bioorg Med Chem Lett; 2003 Jul; 13(13):2113-8. PubMed ID: 12798316
[TBL] [Abstract][Full Text] [Related]
4. From pyrroles to pyrrolo[1,2-a]pyrazinones: a new class of mGluR1 antagonists.
Micheli F; Cavanni P; Di Fabio R; Marchioro C; Donati D; Faedo S; Maffeis M; Sabbatini FM; Tranquillini ME
Bioorg Med Chem Lett; 2006 Mar; 16(5):1342-5. PubMed ID: 16337118
[TBL] [Abstract][Full Text] [Related]
5. Discovery of orally efficacious tetracyclic metabotropic glutamate receptor 1 (mGluR1) antagonists for the treatment of chronic pain.
Wu WL; Burnett DA; Domalski M; Greenlee WJ; Li C; Bertorelli R; Fredduzzi S; Lozza G; Veltri A; Reggiani A
J Med Chem; 2007 Nov; 50(23):5550-3. PubMed ID: 17929793
[TBL] [Abstract][Full Text] [Related]
6. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding.
Litschig S; Gasparini F; Rueegg D; Stoehr N; Flor PJ; Vranesic I; Prézeau L; Pin JP; Thomsen C; Kuhn R
Mol Pharmacol; 1999 Mar; 55(3):453-61. PubMed ID: 10051528
[TBL] [Abstract][Full Text] [Related]
7. Construction of a high affinity zinc binding site in the metabotropic glutamate receptor mGluR1: noncompetitive antagonism originating from the amino-terminal domain of a family C G-protein-coupled receptor.
Jensen AA; Sheppard PO; Jensen LB; O'Hara PJ; Bräuner-Osborne H
J Biol Chem; 2001 Mar; 276(13):10110-8. PubMed ID: 11133983
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one.
Fukuda J; Suzuki G; Kimura T; Nagatomi Y; Ito S; Kawamoto H; Ozaki S; Ohta H
Neuropharmacology; 2009 Sep; 57(4):438-45. PubMed ID: 19559036
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a metabotropic glutamate receptor type 5-green fluorescent protein chimera (mGluR5-GFP): pharmacology, surface expression, and differential effects of Homer-1a and Homer-1c.
Coutinho V; Kavanagh I; Sugiyama H; Tones MA; Henley JM
Mol Cell Neurosci; 2001 Sep; 18(3):296-306. PubMed ID: 11591130
[TBL] [Abstract][Full Text] [Related]
10. Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists.
Costantino G; Pellicciari R
J Med Chem; 1996 Sep; 39(20):3998-4006. PubMed ID: 8831765
[TBL] [Abstract][Full Text] [Related]
11. Correlation of receptor occupancy of metabotropic glutamate receptor subtype 1 (mGluR1) in mouse brain with in vivo activity of allosteric mGluR1 antagonists.
Suzuki G; Kawagoe-Takaki H; Inoue T; Kimura T; Hikichi H; Murai T; Satow A; Hata M; Maehara S; Ito S; Kawamoto H; Ozaki S; Ohta H
J Pharmacol Sci; 2009 Jul; 110(3):315-25. PubMed ID: 19542684
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists.
Zheng GZ; Bhatia P; Daanen J; Kolasa T; Patel M; Latshaw S; El Kouhen OF; Chang R; Uchic ME; Miller L; Nakane M; Lehto SG; Honore MP; Moreland RB; Brioni JD; Stewart AO
J Med Chem; 2005 Nov; 48(23):7374-88. PubMed ID: 16279797
[TBL] [Abstract][Full Text] [Related]
13. From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolines: a new class of orally bioavailable mGluR1 antagonists.
Di Fabio R; Micheli F; Alvaro G; Cavanni P; Donati D; Gagliardi T; Fontana G; Giovannini R; Maffeis M; Mingardi A; Tranquillini ME; Vitulli G
Bioorg Med Chem Lett; 2007 Apr; 17(8):2254-9. PubMed ID: 17276684
[TBL] [Abstract][Full Text] [Related]
14. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
15. Phenylethynyl-pyrrolo[1,2-a]pyrazine: a new potent and selective tool in the mGluR5 antagonists arena.
Micheli F; Bertani B; Bozzoli A; Crippa L; Cavanni P; Di Fabio R; Donati D; Marzorati P; Merlo G; Paio A; Perugini L; Zarantonello P
Bioorg Med Chem Lett; 2008 Mar; 18(6):1804-9. PubMed ID: 18304814
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of novel non-competitive mGluR1 antagonists: a potential treatment for chronic pain.
Owen DR; Dodd PG; Gayton S; Greener BS; Harbottle GW; Mantell SJ; Maw GN; Osborne SA; Rees H; Ringer TJ; Rodriguez-Lens M; Smith GF
Bioorg Med Chem Lett; 2007 Jan; 17(2):486-90. PubMed ID: 17064898
[TBL] [Abstract][Full Text] [Related]
17. In vivo antinociceptive activity of anti-rat mGluR1 and mGluR5 antibodies in rats.
Fundytus ME; Fisher K; Dray A; Henry JL; Coderre TJ
Neuroreport; 1998 Mar; 9(4):731-5. PubMed ID: 9559947
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of aryl isoxazole derivatives as metabotropic glutamate receptor 1 antagonists: a potential treatment for neuropathic pain.
Cho GH; Kim T; Son WS; Seo SH; Min SJ; Cho YS; Keum G; Jeong KS; Koh HY; Lee J; Pae AN
Bioorg Med Chem Lett; 2015 Mar; 25(6):1324-8. PubMed ID: 25677662
[TBL] [Abstract][Full Text] [Related]
19. Role of metabotropic glutamate receptor subtype mGluR1 in brief nociception and central sensitization of primate STT cells.
Neugebauer V; Chen PS; Willis WD
J Neurophysiol; 1999 Jul; 82(1):272-82. PubMed ID: 10400956
[TBL] [Abstract][Full Text] [Related]
20. Investigations on the synthesis and pharmacological properties of 4-alkoxy-2-[2-hydroxy-3-(4-aryl-1-piperazinyl)propyl]-6-methyl-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones.
Sladowska H; Filipek B; Szkatuła D; Sabiniarz A; Kardasz M; Potoczek J; Sieklucka-Dziuba M; Rajtar G; Kleinrok Z; Lis T
Farmaco; 2002 Nov; 57(11):897-908. PubMed ID: 12484538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
